Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BTK | Q06187 | 7/20 | 0.41 |
| ▸ | LYN | P07948 | 4/20 | 0.41 |
| ▸ | JAK1 | P23458 | 4/20 | 0.39 |
| ▸ | TYK2 | P29597 | 4/20 | 0.39 |
| ▸ | JAK2 | O60674 | 1/20 | 0.39 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.39 |
| ▸ | SRC | P12931 | 5/20 | 0.39 |
| ▸ | SLC22A12 | Q96S37 | 3/20 | 0.39 |
| ▸ | SCN9A | Q15858 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27199225 | 1.00 | BTK (0.41) | BTKLYNJAK1TYK2JAK2 | |
| SCHEMBL29638448 | 0.90 | JAK1 (0.41) | BTKLYNJAK1TYK2JAK2 | |
| SCHEMBL24557295 | 0.88 | BTK (0.43) | BTKLYNSRC | |
| SCHEMBL29638577 | 0.88 | BTK (0.43) | BTKLYNSRC | |
| SCHEMBL29638427 | 0.86 | SLC22A12 (0.45) | JAK1TYK2SLC22A12 | |
| SCHEMBL24557272 | 0.83 | BTK (0.45) | BTKLYNJAK1TYK2JAK2 | |
| SCHEMBL24557294 | 0.83 | BTK (0.41) | BTKLYNJAK1TYK2JAK2 | |
| SCHEMBL29638480 | 0.83 | BTK (0.45) | BTKLYNJAK1TYK2JAK2 | |
| SCHEMBL29638402 | 0.83 | BTK (0.41) | BTKLYNJAK1TYK2JAK2 | |
| SCHEMBL29638376 | 0.83 | TYK2 (0.40) | LYNJAK1TYK2SRCMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022136914-A1 | TYK2 INHIBITORS AND USES THEREOF | SUDO BIOSCIENCES LIMITED (GB) | 2022-06-30 | — | — | WO | disclosed |